A new lawsuit was recently filed in Alberta against a host of Canadian cannabis companies for failure to properly label their products. Lisa Marie Langevin alleges that the companies in question are selling products that drastically miscommunicate the actual levels of THC or CBD that are in a bottle.
While the Canadian government allows for a 15% window for makers, Langevin hopes to show that some THC products only contained 46% of the active ingredients advertised. A CBD product was accused of providing 52% of the amount, far outside of acceptable error.
The lawsuit was first filed on June 16, according to a report by the Cannabis Business Times. Aurora Cannabis, Hexo Corp., Tilray Canada, and Emblem Cannabis are some of the defendants in the lawsuit. The CBD company is a subsidiary of Organigram.
Langevin is seeking class-action status for case that is set to take place in the Court of Queen’s Bench of Alberta.
Legal action like this isn’t unprecedented, with many CBD companies in the United States facing similar charges.